Platelet polymorphisms and ischemic heart disease: Moving beyond traditional risk factorsKANDZARI, David E; GOLDSCHMIDT-CLERMONT, Pascal J.Journal of the American College of Cardiology. 2001, Vol 38, Num 4, pp 1028-1032, issn 0735-1097Article

Coronary artery stents: Evaluating new designs for contemporary percutaneous interventionKANDZARI, David E; TCHENG, James E; ZIDAR, James P et al.Catheterization and cardiovascular interventions. 2002, Vol 56, Num 4, pp 562-576, issn 1522-1946Article

The VB-1 catheter: A novel catheter for peripheral arterial revascularizationKANDZARI, David E; ZIDAR, James P; BEHAR, Victor S et al.Catheterization and cardiovascular interventions. 2003, Vol 59, Num 4, pp 514-517, issn 1522-1946, 4 p.Article

Seeking the optimal aspirin dose in acute coronary syndromesKONG, David F; HASSELBLAD, Vic; KANDZARI, David E et al.The American journal of cardiology. 2002, Vol 90, Num 6, pp 622-625, issn 0002-9149Article

Comparison of long-term (seven year) outcomes among patients undergoing percutaneous coronary revascularization with versus without stentingKANDZARI, David E; TUTTLE, Robert H; ZIDAR, James P et al.The American journal of cardiology. 2006, Vol 97, Num 10, pp 1467-1472, issn 0002-9149, 6 p.Article

Long-Term Outcomes of Heart Transplantation Recipients With Transplant Coronary Artery Disease Who Develop In-Stent Restenosis After Percutaneous Coronary InterventionLEE, Michael S; CHENG, Richard K; KANDZARI, David E et al.The American journal of cardiology. 2012, Vol 109, Num 12, pp 1729-1732, issn 0002-9149, 4 p.Article

Longitudinal stent deformation: quantitative coronary angiographic analysis from the PERSEUS and PLATINUM randomised controlled clinical trialsKEREIAKES, Dean J; POPMA, Jeffrey J; STONE, Gregg W et al.EuroIntervention. 2012, Vol 8, Num 2, pp 187-195, issn 1774-024X, 9 p.Article

Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent : Intravascular ultrasound results from ENDEAVOR IIIMIYAZAWA, Akiyoshi; AKO, Junya; HONGO, Yoichiro et al.The American heart journal. 2008, Vol 155, Num 1, pp 108-113, issn 0002-8703, 6 p.Article

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. CommentaryEISENSTEIN, Eric L; ANSTROM, Kevin J; PETERSON, Eric D et al.JAMA, the journal of the American Medical Association. 2007, Vol 297, Num 2, issn 0098-7484, 159-168,209-211 [13 p.]Article

The Petal dedicated bifurcation stentORMISTON, John A; DE VROEY, Frederic; WEBSTER, Mark W. I et al.EuroIntervention. 2010, Vol 6, issn 1774-024X, J139-J142, SUPJArticle

Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: Design and rationale of the GRAVITAS trialPRICE, Matthew J; BERGER, Peter B; ANGIOLILLO, Dominick J et al.The American heart journal. 2009, Vol 157, Num 5, pp 818-824, issn 0002-8703, 7 p.Article

Predictors of Heightened Platelet Reactivity Despite Dual-Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary InterventionPRICE, Matthew J; NAYAK, Keshav R; BARKER, Colin M et al.The American journal of cardiology. 2009, Vol 103, Num 10, pp 1339-1343, issn 0002-9149, 5 p.Article

Effects of pyridoxal-5'-phosphate (MC-1) in patients undergoing high-risk coronary artery bypass surgery: Results of the MEND-CABG randomized studyTARDIF, Jean-Claude; CARRIER, Michel; KANDZARI, David E et al.Journal of thoracic and cardiovascular surgery. 2007, Vol 133, Num 6, pp 1604-1611, issn 0022-5223, 8 p.Article

Zotarolimus-eluting stents in patients with native coronary artery disease : Clinical and angiographic outcomes in 1,317 patientsGERSHLICK, Anthony; KANDZARI, David E; LEON, Martin B et al.The American journal of cardiology. 2007, Vol 100, Num 8B, issn 0002-9149, 41M-55M, SUPArticle

Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC trial)KANDZARI, David E; TCHENG, James E; CARROLL, John D et al.The American journal of cardiology. 2003, Vol 92, Num 7, pp 779-784, issn 0002-9149, 6 p.Article

Reduction of myocardial ischemic injury following coronary intervention the MC-1 to eliminate necrosis and damage trialsKANDZARI, David E; LABINAZ, Marino; KRUCOFF, Mitchell W et al.The American journal of cardiology. 2003, Vol 92, Num 6, pp 660-664, issn 0002-9149, 5 p.Article

A Controlled Trial of Renal Denervation for Resistant HypertensionBHATT, Deepak L; KANDZARI, David E; COHEN, Sidney A et al.The New England journal of medicine. 2014, Vol 370, Num 15, pp 1393-1401, issn 0028-4793, 9 p.Article

The Kinetics of Integrilin Limited by Obesity: A multicenter randomized pharmacokinetic and pharmacodynamic clinical trialVAVALLE, John P; STEVENS, Susanna R; HASSINGER, Nancy et al.The American heart journal. 2011, Vol 162, Num 6, pp 996-1002, issn 0002-8703, 7 p.Article

Comparison by Meta-Analysis of Drug-Eluting Stents and Bare Metal Stents for Saphenous Vein Graft InterventionLEE, Michael S; YANG, Tae; KANDZARI, David E et al.The American journal of cardiology. 2010, Vol 105, Num 8, pp 1076-1082, issn 0002-9149, 7 p.Article

A Qualitative and Quantitative Angiographic Analysis of Stent Fracture Late Following Sirolimus-Eluting Stent ImplantationPOPMA, Jeffrey J; TIROCH, Klaus; ALMONACID, Alexandra et al.The American journal of cardiology. 2009, Vol 103, Num 7, pp 923-929, issn 0002-9149, 7 p.Article

Percutaneous recanalization of chronically occluded coronary arteries : A consensus document Part IISTONE, Gregg W; REIFART, Nicolaus J; MINTZ, Gary S et al.Circulation (New York, N.Y.). 2005, Vol 112, Num 16, pp 2530-2537, issn 0009-7322, 8 p.Article

Feasibility of endovascular cooling as an adjunct to primary percutaneous coronary intervention (Results of the LOWTEMP pilot study)KANDZARI, David E; CHU, Alan; SIGMON, Kristina N et al.The American journal of cardiology. 2004, Vol 93, Num 5, pp 636-639, issn 0002-9149, 4 p.Article

Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-I trial)KANDZARI, David E; GRANGER, Christopher B; LEE, Kerry L et al.The American journal of cardiology. 2004, Vol 93, Num 4, pp 458-461, issn 0002-9149, 4 p.Article

Advanced coronary artery disease: Appropriate end points for trials of novel therapies. EditorialSPERTUS, John; KANDZARI, David E; LA CHOI LAM et al.The American heart journal. 2001, Vol 142, Num 5, pp 745-747, issn 0002-8703, 12 p.Article

A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions: 12-Month Outcomes From the ENDEAVOR IV TrialLEON, Martin B; MAURI, Laura; BALL, Michael W et al.Journal of the American College of Cardiology. 2010, Vol 55, Num 6, pp 543-554, issn 0735-1097, 12 p.Article